Explore
Braveheart Bio, Inc. Common StockBRVE
$18.00-3.12%24H
BRVE / USDNASDAQ
Use arrow keys to change the interval
Equity Info
P/E Ratio—
Market Cap$1.84B
EPS-6.59
52 Week Range$16.70 - $32.00
Volume$15.35M
Liquidity Score—
About Braveheart Bio, Inc. Common Stock

Braveheart Bio, Inc. a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases. The company is headquartered in San Francisco, California.

HeadquartersSAN FRANCISCO, CA

Buy

—
—

Assets

Asset
Braveheart Bio
rBRVE
Reality Finance
Trending
NVDA
NVIDIA Corporation
$151.900.69%
Details
QQQ
Invesco QQQ Trust Series 1
$668.631.37%
Details
SPY
SPDR S&P 500 ETF Trust
$730.090.03%
Details

Help